Prudential Financial’s Xeris Biopharma Holdings XERS Stock Holding History

Prudential Financial’s Portfolio XERS Stock Details XERS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$331K	Sell	57,139 -561,810	-91%	-$3.73M	﹤0.01%	1994
2025 Q4	$4.86M	Sell	618,949 -815,255	-57%	-$6.42M	0.01%	931
2025 Q3	$11.7M	Sell	1,434,204 -122,425	-8%	-$813K	0.01%	603
2025 Q2	$7.27M	Buy	1,556,629 +457,784	+42%	+$2.1M	0.01%	748
2025 Q1	$6.03M	Buy	1,098,845 +1,061,900	+2,874%	+$4.29M	0.01%	765
2024 Q4	$125K	Buy	36,945 +7,000	+23%	+$22.5K	﹤0.01%	2129
2024 Q3	$85.3K	Buy	+29,945	New	+$76.9K	﹤0.01%	2593
2024 Q2	–	Sell	-28,675	Closed	-$63.4K	–	2797
2024 Q1	$63.4K	Sell	28,675 -2,800	-9%	-$7.24K	﹤0.01%	2575
2023 Q4	$74K	Hold	31,475	–	–	﹤0.01%	2520
2023 Q3	$58.5K	Sell	31,475 -127,400	-80%	-$292K	﹤0.01%	2485
2023 Q2	$416K	Buy	+158,875	New	+$404K	﹤0.01%	2198

Other funds holding XERS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Prudential Financial's XERS Position: Q1 2026 in Review

Prudential Financial reduced its Xeris Biopharma Holdings (XERS) stake by 91% in Q1 2026, selling an estimated $3.73M and leaving 57,139 shares worth $331K. The position accounts for ﹤0.01% of the portfolio, ranked #1994.

Prudential Financial first reported a position in XERS in Q2 2023 and has held it in 11 quarters since. The position peaked at $11.7M in Q3 2025. 237 funds tracked by Wall St. Rank hold XERS as of Q1 2026.

Prudential Financial held 57,139 shares of Xeris Biopharma Holdings worth $331K as of Q1 2026.
Prudential Financial sold 561,810 Xeris Biopharma Holdings shares in Q1 2026, an estimated $3.73M.
Xeris Biopharma Holdings made up ﹤0.01% of Prudential Financial's portfolio in Q1 2026, its #1994 holding.
Prudential Financial first reported a position in Xeris Biopharma Holdings in Q2 2023 and has held it in 11 quarters since.
Prudential Financial's Xeris Biopharma Holdings position peaked at $11.7M in Q3 2025.
237 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q1 2026.

Based on Prudential Financial's 13F filing for Q1 2026, filed 13 May 2026.